UNITED
STATES
|
||||||||
SECURITIES
AND EXCHANGE COMMISSION
|
||||||||
WASHINGTON,
DC 20549
|
||||||||
FORM
8-K
|
||||||||
CURRENT
REPORT
|
||||||||
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
||||||||
Date
of report (Date of earliest event reported): November
17,
2008
|
||||||||
CHINA
SKY ONE MEDICAL, INC.
|
||||||||
(Exact
Name of Registrant as Specified in Charter)
|
||||||||
Nevada
|
000-26059
|
87-0430322
|
||||||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
||||||
Room
1706, No. 30 Di Wang Building, Gan Shui Road,
Nangang
District, Harbin, People’s Republic of China 150001
|
||||||||
(Address
of Principal Executive Offices)
|
||||||||
Registrant's
telephone number, including area code: 86-451-53994073
(China)
|
||||||||
(Former
Name or Former Address, if Changed Since Last Report)
|
||||||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions:
Written communications pursuant to Rule 425 under the Securities
Act (17
CFR 230.425)
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Exhibit
No.
|
Description
|
|
3.1
|
Certificate
of Amendment*
|
|
CHINA
SKY ONE MEDICAL, INC.
|
||||
(Registrant)
|
||||
Date:
November
21,
2008
|
By:
/s/
Liu Yan
Qing
|
|||
Liu
Yan Qing
|
||||
Chairman,
Chief Executive Officer and
President
|